Header Logo

Connection

EUGENIE S KLEINERMAN to Immunotherapy, Active

Back to Details
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Immunotherapy, Active.
EUGENIE S KLEINERMAN
Connection Strength
0.009
Immunotherapy, Active
  1. Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma. J Immunother Emphasis Tumor Immunol. 1996 May; 19(3):206-17.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.